6 research outputs found

    Patient characteristics: Random sample of 1002 adults aged 50–80 years in four Swiss university primary care settings.

    No full text
    a<p>Defined as a coronary heart disease (CHD) event in male first-degree relatives <55 years or in female first-degree relatives <65 years.</p>b<p>A former smoker had stopped smoking ≥6 months before baseline and a current smoker was smoking at baseline or had stopped<6 months before baseline.</p>c<p>If the patient has a record of ever having the listed condition or risk factor.</p>d<p>History of transient ischemic attack, cerebral vascular accident, coronary artery disease, angina, myocardial infarction, congestive heart failure or peripheral vascular disease.</p>e<p>Depression, bipolar disorder, psychosis, schizophrenia, pervasive development disorder.</p>f<p>Chronic obstructive pulmonary disease (COPD), asthma, sleep apnea syndrome, sarcoidosis, pulmonary hypertension, bronchiectases, interstitial pulmonary disease or global respiratory insufficiency.</p>g<p>Solid metastatic, solid non-metastatic cancer, lymphoma, leukemia.</p

    Number of comorbidities, Charlson index and quality of preventive care and cardiovascular preventive care, analyzed also for specific subgroups.

    No full text
    a<p>Data adjusted for these patients characteristics: age, sex, civil status, legal status, occupation and center. In a 2nd model we adjusted also for the number of outpatient visits by performing a Sensitivity analyses, which showed similar results.</p>b<p>Based on previous studies<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0096142#pone.0096142-Collet1" target="_blank">[16]</a> and the Charlson index <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0096142#pone.0096142-Charlson1" target="_blank">[20]</a>.</p>c<p>p for trend.</p>d<p>If the patient has a record of ever having the listed condition or risk factor.</p>e<p>History of transient ischemic attack, cerebral vascular accident, coronary artery disease, angina, myocardial infarction, congestive heart failure or peripheral vascular disease.</p>f<p>p-value comparing adjusted data for each subgroup to patients with 0 comorbidities.</p>g<p>Chronic obstructive pulmonary disease (COPD), asthma, sleep apnea syndrome, sarcoidosis, pulmonary hypertension, bronchiectases, interstitial pulmonary disease or global respiratory insufficiency.</p>h<p>Depression, bipolar disorder, psychosis, schizophrenia, pervasive development disorder.</p>i<p>Not further adjusted for legal status because of low number of patients with data on legal status (n = 10 of 19 patients with schizophrenia).</p>j<p>Solid metastatic, solid non-metastatic cancer, lymphoma, leukemia.</p>k<p>Lower care when metastatic cancer only (data not shown, due to small number of 16 patients).</p

    Measures of multimorbidity and association with quality of preventive care.

    No full text
    <p>Left part: Number of comorbidities and percent of provided care for preventive care (blue line) and cardiovascular preventive care (red line), bars showing 95% confidence intervals. Right part: Respective analysis with the Charlson index. Data adjusted for age, sex, civil status, legal status, occupation and treatment center. In a second model we adjusted for number outpatient visits and found similar results.</p
    corecore